普罗布考联合他汀类药物治疗颈动脉斑块的meta分析 The Effect of Probucol Combined with Statins in the Treatment of Carotid Plaque: A Meta-Analysis

Autor: 陈思嘉，潘培炎，陈思琪，彭菲，米东华 (CHEN Sijia, PAN Peiyan, CHEN Siqi, PENG Fei, MI Donghua)

Publikováno v: Zhongguo cuzhong zazhi, Vol 19, Iss 3, Pp 299-309 (2024)

目的 探究普罗布考联合他汀类药物治疗颈动脉斑块的疗效。 方法 以“普罗布考”“他汀”“颈动脉”为中文关键词，检索中文数据库中国知网、维普网、万方数据库，以“carotid artery”“p

Externí odkaz: https://doaj.org/article/6eb52ca7b9704efcbcbc4394ab5e4abb

Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study.

Autor: Zhu H; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China., Chen X; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China., Cai G; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China., Zheng Y; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China., Liu M; Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China., Liu W; Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Yao H; Department of Endocrinology, Navy General Hospital, Beijing, China., Wang Y; Department of Nephrology, General Hospital of Beijing Military Command, Beijing, China., Li W; Department of Nephrology, China-Japan Friendship Hospital, Beijing, China., Wu H; Department of Nephrology, Beijing Hospital, Beijing, China., Lun L; Department of Nephrology, Air Force General Hospital, Beijing, China., Zhang J; Department of Nephrology, General Hospital of Chinese People's Armed Police Forces, Beijing, China., Guan X; Department of Endocrinology, Air Force General Hospital, Beijing, China., Yin S; Department of Endocrinology, First Affiliated Hospital of the General Hospital of Chinese People's Liberation Army, Beijing, China., Zhuang X; Department of Endocrinology, Fuxing Hospital, Capital Medical University, Beijing, China., Li J; Department of Nephrology, First Affiliated Hospital of the General Hospital of Chinese People's Liberation Army, Beijing, China., Liu Y; Department of Endocrinology, 306th Hospital of Chinese People's Liberation Army, Beijing, China., Zhou C; Department of Nephrology, Navy General Hospital, Beijing, China.

Publikováno v: Journal of diabetes [J Diabetes] 2016 Sep; Vol. 8 (5), pp. 677-85. Date of Electronic Publication: 2015 Dec 29.